# Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

> **NCT00005622** · PHASE2 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 72 (actual)

## Conditions studied

- Chronic Myeloproliferative Disorders
- Leukemia
- Multiple Myeloma and Malignant Plasma Cell Neoplasms
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms

## Interventions

- **DRUG:** cyclophosphamide
- **RADIATION:** TBI

## Key facts

- **NCT ID:** NCT00005622
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-05
- **Primary completion:** 2005-09
- **Final completion:** 2009-07
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2012-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005622, "Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00005622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*